Pertussis prevention and treatment: A call for wider access to azithromycin

Medical Journal of Australia

Volumn 190, Issue 7, 2009, Pages 388-389

  Bowen, Asha C ^a,b   Ferson, Mark J ^c   Graudins, Linda V ^a,b   Palasanthiran, Pamela ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Bondi Junction Community Health Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PERTUSSIS VACCINE; ROXITHROMYCIN;

ARTICLE; COMMUNICABLE DISEASE; COST BENEFIT ANALYSIS; COUGHING; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG EXPOSURE; DRUG PREFERENCE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HOSPITAL PHARMACY; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; MEDICAL DECISION MAKING; OCCUPATIONAL EXPOSURE; PATIENT COMPLIANCE; PERTUSSIS; TRACHOMA; TREATMENT DURATION;

EID: 65249183058     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02455.x     Document Type: Article

References (11)

1. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995-2005 - trends by region and age group. Commun Dis Intell 2007; 31: 205-215.
2. Australian Technical Advisory Group on Immunisation. The Australian immunisation handbook. 9th ed. Canberra: Australian Government Department of Health and Ageing, 2008.
3. Antibiotic Expert Group. Therapeutic guidelines: antibiotic version 13. Melbourne: Therapeutic Guidelines, 2006.
4. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007; (3): CD004404.
5. Langley JM, Halperin SA, Boucher FD, Smith B. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004; 114: e96-el0l.
6. Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits: Pharmaceutical Benefits Scheme for health professionals. Azithromycin. http://www.pbs.gov.au/html/healthpro/ search/results?term=azithromycin&scope=PBS+STATIC&form-type= simple (accessed May 2008).
7. NSW Health. Pertussis: response protocol for NSW Public Health Units. Sydney: NSW Health, 2008. http://www.health.nsw.gov.au/factsheets/ guideline/pertusis.html (accessed Sep 2008).
8. Dodhia H, Crowcroft NS, Bramley JC, Miller E. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis. J Public Health Med 2002; 24: 200-206.
9. van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 2006; 20: 1717-1722.
10. Zithromax (azithromycin) product information. Pfizer Australia. Last updated November 2007. Monthly Index of Medical Specialties (MIMS Online). Subscription only. http://proxy8.use.hcn.com.au/ifmx-nsapi/ mimsdata/?Mlval=2MIMS_abbr_pi&product_code=3035&product-name= Zithromax (accessed May 2008).
11. Jarvinen KA, McCall BJ, Nourse CB, et al. Pharmaceutical Benefits Scheme limitations on macrolides: implications for pertussis management [letter]. Med J Aust 2006; 184: 309.